Exercise and cognitive training in… for Parkinson's (NCT06444685)
Improve walking balance and attention
- Trial ID
- NCT06444685
- Official Title
- Motor and Cognitive Effects of Table Tennis on Parkinson's Disease: Pilot Controlled Trial
- Goal
- Improve walking balance and attention
- Phase
- NA
- Status
- UNKNOWN
- Sponsor
- Universitat de Lleida
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease
- Interventions
- Exercise and cognitive training interventino
Summary For Families
It tests whether regular table tennis can improve motor problems like balance, walking, and arm control, while also helping thinking skills such as attention, reaction time, and multitasking in people with early to mid-stage Parkinson's. The approach uses guided table tennis sessions that combine aerobic movement, repetitive arm and trunk use, hand-eye coordination, and fast decision making, activities that may boost motor control and cognitive processing through practice and increased brain blood flow, and it is meant to add to, not replace, usual medications like levodopa. The trial is looking for people aged 40 to 80 with Parkinson's at Hoehn and Yahr stages I to III who can walk 10 minutes unassisted, and excludes those with significant cognitive impairment (MMSE < 23), major vision or hearing loss, serious cardiac limits to exercise, or prior brain surgery.
Locations
- Institut de Recerca Biomèdica de Lleida, Lleida, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exercise and cognitive training interventino. It tests whether regular table tennis can improve motor problems like balance, walking, and arm control, while also helping thinking skills such as attention, reaction time, and multitasking in people with early to mid-stage Parkinson's. The approach uses guided table tennis sessions that combine aerobic movement, repetitive arm and trunk use, hand-eye coordination, and fast decision making, activities that may boost motor control and cognitive processing through practice and increased brain blood flow, and it is meant to add to, not replace, usual medications like levodopa. The trial is looking for people aged 40 to 80 with Parkinson's at Hoehn and Yahr stages I to III who can walk 10 minutes unassisted, and excludes those with significant cognitive impairment (MMSE < 23), major vision or hearing loss, serious cardiac limits to exercise, or prior brain surgery.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- 12 supervised sessions over 6 weeks (twice a week).